Concepedia

Mengyi Du

MD

Statistics

Publications

10

Citations

441

H-Index

10

Active since

2017

Affiliations

Union Hospital(Current)

Huazhong University of Science and Technology

Hubei Cancer Hospital

Union Hospital

Wuhan Union Hospital

Mengyi Du is an author at Union Hospital specializing in medicine, cancer immunology, and chimeric antigen receptor t-cell therapy.

ORCID

Publications per year

2017–2024

10

Publications

10

Characterization of Immune Dysfunction and Identification of Prognostic Immune-Related Risk Factors in Acute Myeloid Leukemia

Lu Tang, Jianghua Wu, Cheng-Gong Li et al. · Clinical Cancer Research · 2020 · 147 citations · Full text

, , +17

Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies

Yinqiang Zhang, Chenggong Li, Mengyi Du et al. · Blood Cancer Journal · 2023 · 78 citations · Full text

, , +16

Energy Efficient Phosphorus Recovery by Microbial Electrolysis Cell Induced Calcium Phosphate Precipitation

Yang Lei, Mengyi Du, Philipp Kuntke et al. · ACS Sustainable Chemistry & Engineering · 2019 · 71 citations · Full text

, , +17

Novel CD19-specific γ/δ TCR-T cells in relapsed or refractory diffuse large B-cell lymphoma

Chenggong Li, Fen Zhou, Jing Wang et al. · Journal of Hematology & Oncology · 2023 · 27 citations · Full text

, , +12

Timing of Tocilizumab Administration Under the Guidance of IL-6 in CAR-T Therapy for R/R Acute Lymphoblastic Leukemia

Yinqiang Zhang, Fen Zhou, Zhuolin Wu et al. · Frontiers in Immunology · 2022 · 26 citations · Full text

, , +17

1–5 of 10